BrainCool AB (publ) (STO:BRAIN)

Market Cap	197.44M -40.1%
Revenue (ttm)	46.13M +13.4%
Net Income	-36.85M
EPS	-0.15
Shares Out	394.88M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	14,715,001
Average Volume	574,905
Open	0.4400
Previous Close	0.4595
Day's Range	0.4400 - 0.5000
52-Week Range	0.4195 - 2.2000
Beta	1.52
RSI	38.37
Earnings Date	Feb 11, 2026

About BrainCool AB

BrainCool AB (publ), a medical device company, together with its subsidiaries, engages in the development, marketing, and sale of medical cooling systems for the healthcare sector in Sweden. The company offers BrainCool system, a system to monitors and controls patient’s temperature to anatomical zones for head/neck, thighs, and torso. It also offers RhinoChill system, a portable and battery-powered cooling product to spray liquid coolant for patient’s nostrils with a catheter, as well as provides Cooral system provides medical professionals an...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2010
• Employees: 20
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: BRAIN

Financial Performance

In 2024, BrainCool AB's revenue was 42.69 million, an increase of 55.79% compared to the previous year's 27.40 million. Losses were -44.04 million, -28.13% less than in 2023.